Feature Channels: Immunology

Filters close
1-Nov-2021 8:00 AM EDT
Pregnant Women with Penicillin Allergy Label Should be Tested to Reduce Antibiotic Exposure
American College of Allergy, Asthma and Immunology (ACAAI)

A new study being presented at this year’s ACAAI Annual Scientific Meeting showed the majority of pregnant women with a penicillin allergy label who were tested were not allergic and could tolerate penicillin during labor.

1-Nov-2021 8:00 AM EDT
New Study Shows Latinos with COVID-19 Had Higher Probability of Developing Asthma Exacerbations
American College of Allergy, Asthma and Immunology (ACAAI)

A new study being presented at this year’s ACAAI Annual Scientific Meeting reveals Latinos with asthma were 4.6 times more likely than Blacks to develop asthma exacerbations (uncontrolled asthma) following COIVD-19, and 2.9 times more likely than whites.

1-Nov-2021 8:00 AM EDT
Cuatro años después de la publicación de las directrices, aún no se informa a los padres sobre la incorporación temprana del cacahuate
American College of Allergy, Asthma and Immunology (ACAAI)

Un nuevo estudio que se presenta en la Reunión científica anual del ACAAI de este año revela que, aunque el 58 % de los encuestados informaron de que su médico de atención primaria (PCP) les habló sobre la incorporación temprana del cacahuate, solo el 40 % de los padres dijo haber recibido una recomendación de incorporar el cacahuate antes de los 11 meses de edad.

1-Nov-2021 8:00 AM EDT
Las posibles reacciones alérgicas a la vacuna contra la COVID-19 no deben significar no ponerse la vacuna
American College of Allergy, Asthma and Immunology (ACAAI)

Dos nuevos estudios que se presentan en la Reunión científica anual del ACAAI de este año muestran que la mayoría de las personas que piensan que tendrán una reacción alérgica, o que creen que han tenido una respuesta alérgica a la primera vacuna, pueden recibir todas las dosis de la vacuna de forma segura.

1-Nov-2021 8:00 AM EDT
A pesar del cambio climático, los niños con asma en Los Ángeles no tuvieron un aumento en los diagnósticos de alergia
American College of Allergy, Asthma and Immunology (ACAAI)

Un nuevo estudio que se presenta en la Reunión científica anual del ACAAI de este año hizo un seguimiento de 5874 niños con asma en Los Ángeles durante 15 años y descubrió que no hubo un aumento de las sensibilizaciones alérgicas.

1-Nov-2021 8:00 AM EDT
La mayoría de personas jóvenes con asma no han recibido una preparación para su transición a la atención del asma en la edad adulta
American College of Allergy, Asthma and Immunology (ACAAI)

Un nuevo estudio que se presenta en la Reunión científica anual del ACAAI de este año revela que la mayoría de los adultos encuestados no recibió preparación suficiente para su transición de parte de sus proveedores de la salud de asma infantil.

1-Nov-2021 8:00 AM EDT
Nuevo estudio muestra que los latinos con COVID-19 tenían una mayor probabilidad de presentar exacerbaciones del asma
American College of Allergy, Asthma and Immunology (ACAAI)

Un nuevo estudio que se presenta en la Reunión científica anual del ACAAI de este año revela que la población latina con asma tenían 4.6 veces más probabilidad que la población negra de presentar exacerbaciones del asma (asma no controlada) después de la COVID-19 y 2.9 veces más probabilidad que la población blanca.

1-Nov-2021 8:00 AM EDT
El aumento de la frecuencia de comer huevos en el primer año de vida se asocia con menos probabilidades de tener alergia al huevo más adelante
American College of Allergy, Asthma and Immunology (ACAAI)

Un nuevo estudio que se presenta en la Reunión científica anual del ACAAI de este año revela que la incorporación temprana del huevo está asociada con una menor probabilidad de tener alergia al huevo.

1-Nov-2021 8:00 AM EDT
Caso médicamente desafiante muestra que los AINE pueden provocar anafilaxia inducida por ejercicio
American College of Allergy, Asthma and Immunology (ACAAI)

Un nuevo caso médicamente difícil presentado en la Reunión Científica Anual del ACAAI de este año informa de una situación en la que un medicamento antinflamatorio no esteroideo (AINE) causó una reacción anafiláctica en una maratonista.

1-Nov-2021 8:00 AM EDT
Despite Climate Change, Kids with Asthma in Los Angeles Didn’t Have an Increase in Allergy Diagnoses
American College of Allergy, Asthma and Immunology (ACAAI)

A new study being presented at this year’s ACAAI Annual Scientific Meeting followed 5,874 kids with asthma in Los Angeles for 15 years and found no increase in allergic sensitizations.

Released: 4-Nov-2021 8:00 AM EDT
Cancer Research Institute to Honor Developers of COVID-19 mRNA Vaccines in Historic Gathering: “This Technology Will Play a Big Role in Cancer Treatment”
Cancer Research Institute

CRI will bestow the 2021 William B. Coley Award for Distinguished Research in Basic Immunology on four mRNA vaccine scientists followed by roundtable on origin and future application to cancer treatment.

Newswise: Unexpected Antibody Type Found in People with Malaria Infections
Released: 2-Nov-2021 3:55 PM EDT
Unexpected Antibody Type Found in People with Malaria Infections
University of Maryland School of Medicine

In a newly published study, researchers at the University of Maryland School of Medicine have detected antibodies primarily made in response to infections in the mucous membranes — in such areas as the lungs, intestines, or vagina — in study participants with malaria.

Released: 2-Nov-2021 11:10 AM EDT
COVID-19 Vaccine Gets Strong Response in Some With Weak Immunity
Cedars-Sinai

Researchers at Cedars-Sinai found that patients with inflammatory bowel disease (IBD)─whose treatment can weaken the immune system─produced a strong antibody response to COVID-19 vaccination. The study findings have been published in the Annals of Internal Medicine.

Released: 2-Nov-2021 10:00 AM EDT
Duke, UNC-Chapel Hill Scientists Identify New Antibody For COVID-19 and Variants
Duke Health

A research collaboration between scientists at Duke University and the University of North Carolina at Chapel Hill has identified and tested an antibody that limits the severity of infections from a variety of coronaviruses, including those that cause COVID-19 as well as the original SARS illness.

Released: 1-Nov-2021 2:00 PM EDT
In Covid-19 Vaccinated People, Those with Prior Infection Likely to Have More Antibodies
Johns Hopkins Medicine

In what is believed to be one of the largest studies of its kind, Johns Hopkins Medicine researchers have shown that antibody levels against SARS-CoV-2 (the COVID-19 virus) stay more durable — that is, remain higher over an extended period of time — in people who were infected by the virus and then received protection from two doses of messenger RNA (mRNA) vaccine compared with those who only got immunized.

Released: 28-Oct-2021 2:35 PM EDT
Novel Therapeutic Strategies May Finally Bring Relief to Those Suffering from Asthma and Allergies
Rutgers University's Office for Research

Asthma and allergies are chronic health conditions that continue to adversely impact the quality of life for many around the world. Thanks to exciting breakthroughs by Mark Siracusa, a researcher at Rutgers, The State University of New Jersey, there may be early signs of light at the end of the tunnel.

Released: 27-Oct-2021 3:00 PM EDT
The EcoHealth Alliance experiments have nothing to do with the COVID-19 pandemic
Newswise

There is no evidence that Fauci knowingly gave false information when asked about the NIH funding of " gain-of-function research" when it comes to the coronavirus. In fact, the letter itself notes that the viruses used in the experiments are “decades removed from SARS-CoV-2 evolutionarily” and that they “could not have been the source of SARS-CoV-2.”

   
Released: 27-Oct-2021 10:40 AM EDT
More than 75% of Texans have COVID-19 antibodies, one of the world’s largest assessments finds
University of Texas Health Science Center at Houston

A year after launching one of the world’s largest COVID-19 antibody surveys, Texas CARES, public health experts at The University of Texas Health Science Center at Houston (UTHealth Houston) and the Texas Department of State Health Services (DSHS) are estimating that over 75% of Texans have COVID-19 antibodies.

Newswise: Long-term immune response to Sputnik-V COVID vaccine
Released: 27-Oct-2021 8:40 AM EDT
Long-term immune response to Sputnik-V COVID vaccine
Kazan Federal University

The contributors are Kazan Federal University, Kazan State Medical Academy, Thapar Institute of Engineering and Technology, and the University of Liverpool.

Released: 22-Oct-2021 4:25 PM EDT
COVID vaccine booster increases antibody responses, is protective in rhesus macaques
NIH, National Institute of Allergy and Infectious Diseases (NIAID)

A booster dose of the mRNA-1273 COVID-19 vaccine given to rhesus macaques about six months after their primary vaccine series significantly increased levels of neutralizing antibodies against all known SARS-CoV-2 variants of concern, according to a new study from National Institutes of Health scientists and colleagues.



close
2.80215